Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1985 1
1987 1
1989 1
1990 1
1991 1
2004 1
2006 2
2007 2
2015 2
2016 1
2017 1
2018 1
2020 1
2021 1
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.
Bateman RJ, Smith J, Donohue MC, Delmar P, Abbas R, Salloway S, Wojtowicz J, Blennow K, Bittner T, Black SE, Klein G, Boada M, Grimmer T, Tamaoka A, Perry RJ, Turner RS, Watson D, Woodward M, Thanasopoulou A, Lane C, Baudler M, Fox NC, Cummings JL, Fontoura P, Doody RS; GRADUATE I and II Investigators and the Gantenerumab Study Group. Bateman RJ, et al. N Engl J Med. 2023 Nov 16;389(20):1862-1876. doi: 10.1056/NEJMoa2304430. N Engl J Med. 2023. PMID: 37966285 Clinical Trial.
Effect of surgical experience and spine subspecialty on the reliability of the AO Spine Upper Cervical Injury Classification System.
Lambrechts MJ, Schroeder GD, Karamian BA, Canseco JA, Oner FC, Benneker LM, Bransford RJ, Kandziora F, Rajasekaran S, El-Sharkawi M, Kanna R, Joaquim AF, Schnake K, Kepler CK, Vaccaro AR; AO Spine Upper Cervical Injury Classification International Members; AO Spine Upper Cervical Injury Classification International Members. Lambrechts MJ, et al. J Neurosurg Spine. 2022 Aug 19;38(1):31-41. doi: 10.3171/2022.6.SPINE22454. Print 2023 Jan 1. J Neurosurg Spine. 2022. PMID: 35986731 Free PMC article.
METHODS: A total of 11,601 assessments of upper cervical spine injuries were evaluated based on the AO Spine Upper Cervical Injury Classification System. Reliability and reproducibility scores were obtained twice, with a 3-week time interval. ...CONCLUSIONS: The internatio …
METHODS: A total of 11,601 assessments of upper cervical spine injuries were evaluated based on the AO Spine Upper Cervical Injury Cl …
Ultrasonographic evaluation of the caudal vena cava in dogs with right-sided heart disease.
Fujioka T, Nakamura K, Minamoto T, Tsuzuki N, Yamaguchi J, Hidaka Y. Fujioka T, et al. J Vet Cardiol. 2021 Apr;34:80-92. doi: 10.1016/j.jvc.2021.01.005. Epub 2021 Jan 24. J Vet Cardiol. 2021. PMID: 33626419
RESULTS: We obtained the highest accuracies of the ratio of the shortest diameter (SD) of the minimal CVC area to the aorta diameter (Ao) during inspiration [SD(min)/Ao] and of the ratio of SD(min) to the longest diameter of the minimal CVC area during inspiration [ …
RESULTS: We obtained the highest accuracies of the ratio of the shortest diameter (SD) of the minimal CVC area to the aorta diameter (Ao …
How to introduce a rotigotine patch to Parkinson's disease patients taking oral dopamine agonists.
Yasutaka Y, Fujioka S, Mishima T, Shibaguchi H, Tsuboi Y, Kamimura H. Yasutaka Y, et al. Clin Neurol Neurosurg. 2020 Dec;199:106266. doi: 10.1016/j.clineuro.2020.106266. Epub 2020 Oct 1. Clin Neurol Neurosurg. 2020. PMID: 33059317
OBJECTIVE: Ways of introducing a rotigotine patch to Parkinson disease (PD) patients include initial induction for dopamine agonist (DA)-free patients and overnight switch (OS), cross-titration (CT), and add-on (AO) for patients already taking oral DAs. We investigated whe …
OBJECTIVE: Ways of introducing a rotigotine patch to Parkinson disease (PD) patients include initial induction for dopamine agonist (DA)-fre …
Transcardiac adiponectin gradient is independently related to endothelial vasomotor function in large and resistance coronary arteries in humans.
Takano H, Kodama Y, Kitta Y, Nakamura T, Obata JE, Mende A, Kawabata K, Saitoh Y, Fujioka D, Kobayashi T, Hasebe H, Kugiyama K. Takano H, et al. Am J Physiol Heart Circ Physiol. 2006 Dec;291(6):H2641-6. doi: 10.1152/ajpheart.00702.2006. Epub 2006 Jul 28. Am J Physiol Heart Circ Physiol. 2006. PMID: 16877558 Free article.
Adiponectin levels were measured by ELISA in plasma obtained from the aortic root (Ao) and the anterior interventricular vein (AIV). Adiponectin levels in the AIV were lower than levels in the Ao. In multivariate linear regression analysis, the transcardiac gradient …
Adiponectin levels were measured by ELISA in plasma obtained from the aortic root (Ao) and the anterior interventricular vein (AIV). …
Relation between transcardiac gradient of VEGF and coronary flow response in humans.
Mende A, Takano H, Kodama Y, Nakamura T, Umetani K, Fujioka D, Saito Y, Kobayashi T, Kawabata K, Obata JE, Kitta Y, Kugiyama K. Mende A, et al. Int J Cardiol. 2007 Jul 10;119(2):156-62. doi: 10.1016/j.ijcard.2006.07.112. Epub 2006 Oct 24. Int J Cardiol. 2007. PMID: 17067705
Circulating VEGF levels were measured by ELISA in plasma obtained from the aortic root (AO) and anterior interventricular vein (AIV). RESULTS: The transcardiac gradient of VEGF, calculated by the difference in VEGF concentrations between the AIV and AO, showed a pos …
Circulating VEGF levels were measured by ELISA in plasma obtained from the aortic root (AO) and anterior interventricular vein (AIV). …
Angiotensin II receptor blockers suppress the release of stromal cell-derived factor-1α from infarcted myocardium in patients with acute myocardial infarction.
Yoshizaki T, Uematsu M, Obata JE, Nakamura T, Fujioka D, Watanabe K, Nakamura K, Kugiyama K. Yoshizaki T, et al. J Cardiol. 2018 Apr;71(4):367-374. doi: 10.1016/j.jjcc.2017.10.002. Epub 2017 Nov 10. J Cardiol. 2018. PMID: 29129394 Free article.
METHODS: SDF-1alpha levels were measured by enzyme-linked immunosorbent assays in plasma obtained from the aortic root (AO) and the anterior interventricular vein (AIV) in 50 patients with an anterior AMI. ...Patients were divided into 2 groups according to treatment with …
METHODS: SDF-1alpha levels were measured by enzyme-linked immunosorbent assays in plasma obtained from the aortic root (AO) and the a …
Myocardial Production of Plasminogen Activator Inhibitor-1 is Associated with Coronary Endothelial and Ventricular Dysfunction after Acute Myocardial Infarction.
Shimizu T, Uematsu M, Yoshizaki T, Obata JE, Nakamura T, Fujioka D, Watanabe K, Watanabe Y, Kugiyama K. Shimizu T, et al. J Atheroscler Thromb. 2016 May 2;23(5):557-66. doi: 10.5551/jat.32300. Epub 2015 Dec 2. J Atheroscler Thromb. 2016. PMID: 26632165 Free article.
METHODS: Plasma levels of PAI-1 activity and tissue-plasminogen activator (tPA) antigen were measured 2 weeks and 6 months after MI by ELISA in plasma obtained from the aortic root (AO) and anterior interventricular vein (AIV) in 28 patients with a first AMI due to occlusi …
METHODS: Plasma levels of PAI-1 activity and tissue-plasminogen activator (tPA) antigen were measured 2 weeks and 6 months after MI by ELISA …
Sirolimus-eluting stent implantation aggravates endothelial vasomotor dysfunction in the infarct-related coronary artery in patients with acute myocardial infarction.
Obata JE, Kitta Y, Takano H, Kodama Y, Nakamura T, Mende A, Kawabata K, Saitoh Y, Fujioka D, Kobayashi T, Yano T, Kugiyama K. Obata JE, et al. J Am Coll Cardiol. 2007 Oct 2;50(14):1305-9. doi: 10.1016/j.jacc.2007.06.031. Epub 2007 Sep 17. J Am Coll Cardiol. 2007. PMID: 17903627 Free article. Clinical Trial.
Levels of vascular endothelial growth factor (VEGF) were measured by enzyme-linked immunoadsorbent assay in plasma obtained from the aortic root (AO) and the anterior interventricular vein (AIV) in all patients. ...Vascular endothelial growth factor levels in the AIV were …
Levels of vascular endothelial growth factor (VEGF) were measured by enzyme-linked immunoadsorbent assay in plasma obtained from the aortic …
Metabolic improvements associated with a reduction of abdominal visceral fat caused by a new alpha-glucosidase inhibitor, AO-128, in Zucker fatty rats.
Kobatake T, Matsuzawa Y, Tokunaga K, Fujioka S, Kawamoto T, Keno Y, Inui Y, Odaka H, Matsuo T, Tarui S. Kobatake T, et al. Int J Obes. 1989;13(2):147-54. Int J Obes. 1989. PMID: 2663746
An increase in mesenteric fat cell volume was thus more predominant than that of subcutaneous fat cells in the fatty rats. Administration of AO-128 (50 p.p.m./day), a new alpha-glucosidase inhibitor, caused a substantial reduction of mesenteric fat weight accompanied by a …
An increase in mesenteric fat cell volume was thus more predominant than that of subcutaneous fat cells in the fatty rats. Administration of …
17 results